Research Spotlight: Magnetofection™ platform: From magnetic nanoparticles to novel nucleic acid therapeutics

Christian Plank, Dialechti Vlaskou, Ulrike Schillinger, Olga Mykhaylyk

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Nucleic acid delivery to cells to make them produce a desired protein or to shut down the expression of endogenous genes opens unique possibilities for research and therapy. During the last decade, to realize the potential of this approach, nanomagnetic methods for delivering and targeting nucleic acids have been developed, methods which are often referred to as Magnetofection™. Our research group at the Institute of Experimental Oncology and Therapy Research, located at the University Hospital Klinikum rechts der Isar in the center of Munich, Germany, develops new magnetic nanomaterials and, their formulations with gene-delivery vectors and technologies to allow localized and efficient gene delivery in vitro and in vivo for a variety of research, diagnostic and therapeutic applications.

Original languageEnglish
Pages (from-to)717-726
Number of pages10
JournalTherapeutic Delivery
Volume2
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Dive into the research topics of 'Research Spotlight: Magnetofection™ platform: From magnetic nanoparticles to novel nucleic acid therapeutics'. Together they form a unique fingerprint.

Cite this